Tetanus booster every 5 years: an unnecessary routine?CHIKHANI, C. G; KUMAR, K.Archives of emergency medicine. 1988, Vol 5, Num 1, pp 4-11, issn 0264-4924Article

Midwife attitudes: An important determinant of maternal postpartum pertussis booster vaccinationCHENOA COOPER ROBBINS, Spring; LEASK, Julie; HELEN HAYLES, Elizabeth et al.Vaccine. 2011, Vol 29, Num 34, pp 5591-5594, issn 0264-410X, 4 p.Article

Safe and effective booster immunization using DTaP in teenagersOKADA, Kenji; KOMIYA, Takako; YAMAMOTO, Akihiko et al.Vaccine. 2010, Vol 28, Num 48, pp 7626-7633, issn 0264-410X, 8 p.Article

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?ZENT, Olaf; PLENTZ, Annelie; SCHWARZ, Tino F et al.Vaccine. 2004, Vol 23, Num 3, pp 312-315, issn 0264-410X, 4 p.Article

Booster immunisation for diphteria and tetanus: no evidence of need in adultsMATHIAS, R. G; SCHECHTER, M. T.Lancet (British edition). 1985, Vol 1, Num 8437, pp 1089-1091, issn 0140-6736Article

Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policyPARANTHAMAN, K; BUNCE, A.Epidemiology and infection. 2012, Vol 140, Num 9, pp 1612-1616, issn 0950-2688, 5 p.Article

Postpartum prevention of pertussis in a French maternity hospital: Impact on general practitionersLEBOUCHER, Bertrand; ABBOU, Fatma; GASCOIN, Géraldine et al.Vaccine. 2013, Vol 31, Num 44, pp 5118-5126, issn 0264-410X, 9 p.Article

Short-term booster effect of diphtheria toxoid in initially long-term protected individualsDANILOVA, Elena; SHIRYAYEV, Alexey; SKOGEN, Vegard et al.Vaccine. 2005, Vol 23, Num 12, pp 1446-1450, issn 0264-410X, 5 p.Article

Efficacité immunologique de l'immunisation de rappel contre la rougeole chez des enfants restant séronégatifs après immunisation primaireBOLOTOVSKIJ, V. M; GELIKMAN, B. G; TITOVA, N. S et al.Žurnal mikrobiologii, èpidemiologii i immunobiologii. 1984, Num 7, pp 100-106, issn 0372-9311Article

Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of ageAASE, Audun; HERSTAD, Tove Karin; JØRGENSEN, Silje Bakken et al.Vaccine. 2014, Vol 32, Num 45, pp 5931-5936, issn 0264-410X, 6 p.Article

Réaction locale majeure après rappel de vaccination antitétanique et anditiphtérique = Booster tetanos diphteria vaccination: a case with severe local reactionBOLES, J. M.Médecine et maladies infectieuses. 1985, Vol 15, Num 10, pp 558-560, issn 0399-077XArticle

Antibody persistence of two pentavalent DTwP―HB―Hib vaccines to the age of 15―18 months, and response to the booster dose of quadrivalent DTwP―Hib vaccineSHARMA, Hitt; YADAV, Sangeeta; SHEWALE, Sunil et al.Vaccine. 2013, Vol 31, Num 3, pp 444-447, issn 0264-410X, 4 p.Article

Rationale for pertussis booster vaccination throughout life in EuropeZEPP, Fred; HEININGER, Ulrich; MERTSOLA, Jussi et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 7, pp 557-570, issn 1473-3099, 14 p.Article

High tetanus and diphtheria antitoxin concentrations in Finnish adults―Time for new booster recommendations?OLANDER, R.-M; AURANEN, K; HARKANEN, T et al.Vaccine. 2009, Vol 27, Num 39, pp 5295-5298, issn 0264-410X, 4 p.Article

Supprimons la rougeole avec une deuxième dose de vaccin = Stopping measles with a second vaccine dosePELTOLA, H.Archives de pédiatrie (Paris). 1998, Vol 5, Num 6, pp 599-601, issn 0929-693XArticle

Is booster dose of BCG vaccine necessary?UDANI, P. M.Indian journal of pediatrics. 1989, Vol 56, Num 3, pp 311-314, issn 0019-5456, 4 p.Article

On revising the time of revaccination of children against measlesRUSAKOVA, E. V; BEZUGLOVA, M. S; VASILYEVA, V. I et al.Žurnal mikrobiologii, èpidemiologii i immunobiologii. 1991, Num 8, pp 51-54, issn 0372-9311Article

Waning immunity to measles in young adults and booster effects of revaccination in secondary school studentsHANQING HE; CHEN, En-Fu; QIAN LI et al.Vaccine. 2013, Vol 31, Num 3, pp 533-537, issn 0264-410X, 5 p.Article

Antibody Persistence after 2-Dose Priming and Booster Response to a Third Dose of an Inactivated, Adjuvanted, Whole-Virion H5N1 VaccineLIN, Jiang-Tao; LI, Chang-Gui; YIN, Wei-Dong et al.The Journal of infectious diseases. 2009, Vol 199, Num 2, pp 184-187, issn 0022-1899, 4 p.Article

Booster Vaccinations against Cancer Are Critical in Prophylactic but Detrimental in Therapeutic SettingsRICUPITO, Alessia; GRIONI, Matteo; CALCINOTTO, Arianna et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 12, pp 3545-3554, issn 0008-5472, 10 p.Article

The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccineFISHBEIN, D. B; BERNARD, K. W; PINSKY, P. F et al.The American journal of tropical medicine and hygiene. 1986, Vol 35, Num 3, pp 663-670, issn 0002-9637Article

BOOSTER VACCINATION WITH FURTHER LIVE ATTENUATED MEASLES VACCINE = VACCINATION DE RAPPEL AVEC DAVANTAGE DE VACCIN ANTIROUGEOLEUX VIVANT ATTENUEBASS JW; HALSTEAD SB; FISCHER GW et al.1976; J. AMER. MED. ASS.; U.S.A.; DA. 1976; VOL. 235; NO 1; PP. 31-34; BIBL. 14 REF.Article

WIRKSAMKEIT VON TETANUSAUFFRISCHIMPFUNGEN, VERMEIDUNG VON HYPERIMMUNISIERUNGEN = EFFICACITE DES VACCINATIONS ANTITETANIQUES DE RAPPEL, PREVENTION DES HYPERIMMUNISATIONSHARRFELDT HP.1975; MONATSSCHR. UNFALLHEILKDE; DTSCH.; DA. 1975; VOL. 78; NO 1; PP. 25-34; ABS. ANGL.; BIBL. 15REF.Article

MEASLES IMMUNITY: REIMMUNIZATION OF CHILDREN WHO PREVIOUSLY RECEIVED LIVE MEASLES VACCINE AND GAMMA GLOBULINARBETER AM; ARTHUR JH; BLAKEMAN GJ et al.1972; J. PEDIATR.,; U.S.A.; DA. 1972; VOL. 81; NO 4; PP. 737-741; BIBL. 11REF.Serial Issue

RECHERCHE DU MOMENT OPTIMUM POUR LA VACCINATION ET LA REVACCINATION AU COURS DE L'IMMUNISATION EN DEUX ETAPES DE POULETS CONTRE LA MALADIE DE NEWCASTLELARSKI Z; GRABOWSKA G; WISNIEWSKI J et al.1976; MED. WETER.; POLSKA; DA. 1976; VOL. 32; NO 7; PP. 399-401; ABS. RUSSE ANGL.; BIBL. 12 REF.Article